Univest
Univest
  • Markets

Bodal Chemicals Q4 FY26 Results: PAT Rs 32 Cr

  • May 22, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Bodal Chemicals

Bodal Chemicals Q4 FY26 results were declared on May 21, 2026. The company reported PAT of Rs 32 crore for the quarter ended March 31, 2026, up 113.0% YoY compared to Rs 15 crore in Q4 FY25. Revenue from operations stood at Rs 588 crore, up 30.0% YoY. Results are on a Consolidated basis. Bodal Chemicals is a Dyes and Chemicals company listed on Indian stock exchanges.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Bodal Chemicals Q4 FY26 Financial Highlights
  • Bodal Chemicals Q4 FY26 Performance Analysis
  • Key Factors Driving Bodal Chemicals Q4 FY26 Results
    • Revenue and Business Performance
    • Profitability and Margins
    • India Macro Backdrop
    • FY27 Outlook
  • Frequently Asked Questions on the company
    • What is Bodal Chemicals Q4 FY26 net profit?
    • What is Bodal Chemicals Q4 FY26 revenue?
    • When were Bodal Chemicals Q4 FY26 results declared?
    • Is Bodal Chemicals a good investment after Q4 FY26?
  • Also Read

Bodal Chemicals Q4 FY26 Financial Highlights

Metric Q4 FY26 (Rs Cr) Q4 FY25 (Rs Cr) YoY Change
Revenue 588 451 +30.0%
Gross Profit Rs 51 crore 30 +70.0%
Net Profit 32 15 +113.0%
Basis Consolidated

Note: Bodal Chemicals Q4 FY26 results declared May 21, 2026. Verify from BSE/NSE audited filings before investment decisions.

Bodal Chemicals Q4 FY26 Performance Analysis

The Bodal Chemicals Q4 FY26 results reflect the company’s operational performance in the January to March 2026 quarter. Strong PAT growth of 113% YoY to Rs 32 crore demonstrates significant earnings improvement. Bodal Chemicals operates in the Dyes and Chemicals sector, which benefited from India’s GDP growth above 6.5% in FY26.

Revenue grew 30% YoY to Rs 588 crore, driven by strong demand and business expansion.

Screen the best stocks on the Univest Screener.

Key Factors Driving Bodal Chemicals Q4 FY26 Results

Revenue and Business Performance

Bodal Chemicals Q4 FY26 revenue of Rs 588 crore was up 30.0% YoY. The strong revenue growth reflects market share gains, capacity expansion, and healthy demand conditions.

Profitability and Margins

the business PAT of Rs 32 crore up 113.0% YoY. The strong PAT growth demonstrates improving operational leverage and cost discipline.

India Macro Backdrop

The January to March 2026 quarter benefited from India’s GDP growth above 6.5%, government capital expenditure of Rs 11.21 lakh crore for FY27, and resilient domestic consumption. RBI’s accommodative stance supported credit and demand conditions. The Dyes and Chemicals sector saw strong tailwinds during this period.

FY27 Outlook

Following the firm results, management commentary on FY27 revenue guidance, margin expansion roadmap, and capital allocation will be key investor watchpoints. The Dyes and Chemicals sector continues to benefit from India’s long-term structural growth.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on the company

What is Bodal Chemicals Q4 FY26 net profit?

Ans. Bodal Chemicals Q4 FY26 PAT of Rs 32 crore, up 113.0% YoY from Rs 15 crore in Q4 FY25. Results declared May 21, 2026, on a Consolidated basis.

What is Bodal Chemicals Q4 FY26 revenue?

Ans. Bodal Chemicals Q4 FY26 revenue from operations was Rs 588 crore, up 30.0% YoY. Verify from BSE/NSE filings.

When were Bodal Chemicals Q4 FY26 results declared?

Ans. Bodal Chemicals Q4 FY26 results were declared on May 21, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.

Is Bodal Chemicals a good investment after Q4 FY26?

Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk. This article is for educational purposes only. Consult a SEBI-registered financial advisor before investing.

Also Read

  • LIC Q4 FY26 Results: PAT Rs 23,420 Crore
  • JSW Cement Q4 FY26 Results: PAT Rs 356 Crore
  • Prestige Estates Q4 FY26 Results: PAT Rs 327 Crore
  • Univest Blogs: Latest Stock Market Research and Analysis

Investments in securities are subject to market risk. This content is for educational purposes only. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.



News Q4 Results
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply